Array
(
[1611344362] => Array
(
[wordfence_processAttackData] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] =>
[args] => Array
(
)
)
)
)
[1611344373] => Array
(
[wp_privacy_delete_old_export_files] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1611344881] => Array
(
[wpm_update_stats] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1611346392] => Array
(
[wordfence_hourly_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => hourly
[args] => Array
(
)
[interval] => 3600
)
)
)
[1611351661] => Array
(
[wpseo_permalink_structure_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
[wpseo_home_url_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611351674] => Array
(
[wpseo-reindex] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611365526] => Array
(
[wp_update_themes] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
[wp_update_plugins] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1611368953] => Array
(
[wp_version_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1611371873] => Array
(
[wp_session_garbage_collection] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => twicedaily
[args] => Array
(
)
[interval] => 43200
)
)
)
[1611383085] => Array
(
[recovery_mode_clean_expired_keys] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611385712] => Array
(
[ai1wm_storage_cleanup] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611391771] => Array
(
[wp_scheduled_auto_draft_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611396911] => Array
(
[delete_expired_transients] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611396952] => Array
(
[wpseo-reindex-links] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611397614] => Array
(
[wordfence_daily_cron] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611409474] => Array
(
[wp_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611418024] => Array
(
[akismet_scheduled_delete] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611421011] => Array
(
[yoast_tracking] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => daily
[args] => Array
(
)
[interval] => 86400
)
)
)
[1611496200] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[afad825ab071aef2728c7c04da62fda2] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1611496200
)
)
)
)
[1611728690] => Array
(
[wp_site_health_scheduled_check] => Array
(
[40cd750bba9870f18aada2478b24840a] => Array
(
[schedule] => weekly
[args] => Array
(
)
[interval] => 604800
)
)
)
[1611755400] => Array
(
[wordfence_start_scheduled_scan] => Array
(
[107e7d3e78442fe8efdb48fdb9e94dbb] => Array
(
[schedule] =>
[args] => Array
(
[0] => 1611755400
)
)
)
)
)
Etiquetas: AINE, Ana Cosín, Antiasmáticos, Barcelona, D-VALOR, El valor de la dispensación, Estatinas, Farmacéuticos comunitarios, Farmacia comunitaria, Farmacovigilancia, Formación, Mejorar la calidad asistencial, Mylan, Nancy Solá, Noviembre 2012, Programa de investigación, Protocolizar, Raquel Cámara, salud, Sanidad.
Etiquetas: 2006, Actitud diagnóstica y terapéutica, AINE, Anamnesis, Angiografía carotídea o vertebral, Antidepresivos, Antiserotonínicos, Aproximación diagnóstica al paciente con cefalea, Aura persistente sin infarto, Aura típica con cefalea no migrañosa, Aura típica sin cefalea, Calcioantagonistas, Cambios neuroquímicos, Cefalea, Cefalea de tensión, Cefalea en racimos, Cefaleas primarias, Cefaleas secundarias, Clasificación Internacional de las cefaleas 2004, Complicaciones de la migraña, Crisis epiléptica desencadenada por migraña, Depresión cortical propagada, EEG, Electroencefalografía, Ergon, Estructuras antinociceptivas, GLAXOSMITHKLINE, Grupo de Estudio de Cefalea, GSK, Historia Clínica, IHS, Infarto migrañoso, International Headache Society, Jesús Porta Etessam, Libro, Madrid, Mariano Huerta Villanueva, MHF, Migraña, Migraña abdominal, Migraña con aura, Migraña con aura típica, Migraña crónica, Migraña de tipo basilar, Migraña hemipléjica esporádica, Migraña hemipléjica familiar, Migraña probable, Migraña retiniana, Neuralgias craneales, Neuroimagen, Neurología, Neurólogos, Otras cefaleas trigémino-autonómicas, Paciente, Pacientes con migraña, Patología neurológica, Patricia Pozo Rosich, Punción lumbar, Radiología simple, Raquis cervical, recomendaciones, Reflejos, salud, Samuel Díaz Insa, Sanidad, SGP, Síndromes periódicos en la infancia que pueden ser precursores o estar asociados a migraña, Sistema trigémino vascular, Sociedad Española de Neurología, STV, sustancia gris periacueductal, Tratamiento, Tratamiento farmacológico de las cefaleas primarias y algias faciales, Valentín Mateos Marcos, Vértigo paroxístico benigno de la infancia, Vómitos cíclicos.
Etiquetas: 1 septiembre 2007, 26 Junio 2007, AEMPS, Agencia Española de medicamentos, Agencia española de medicamentos y productos sanitarios, AINE, Antiinflamatorios, CHMP, Complicaciones gastrointestinales, Comunicación, Diagnóstico hopitalario, EMEA, Emilio Vargas Castrillón, Finalización del arbitraje europeo con nuevas restricciones de uso y paso a diagnóstico hospitalario, Instrucciones a los pacientes, Madrid, medicamentos, Medidas que se adoptarán en España, Ministerio de Sanidad y Consumo, No estiroideos, Nota informativa, Piroxicam, Preparados tópicos, Profesionales sanitarios, Reacciones cutáneas, Riesgos, salud, Sanidad.
.gif)